{"id":98739,"date":"2026-01-08T23:03:06","date_gmt":"2026-01-08T23:03:06","guid":{"rendered":"https:\/\/www.europesays.com\/lv\/98739\/"},"modified":"2026-01-08T23:03:06","modified_gmt":"2026-01-08T23:03:06","slug":"zinatnieki-izstradajusi-spoguli-kas-var-prognozet-naves-risku-lente-lv","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/lv\/98739\/","title":{"rendered":"Zin\u0101tnieki izstr\u0101d\u0101ju\u0161i spoguli, kas var prognoz\u0113t n\u0101ves risku\u00a0\u2014\u00a0Lente.lv"},"content":{"rendered":"<p>Jaun\u0101k\u0101s tehnolo\u0123ijas CES 2026: Spogulis, kas var nolas\u012bt j\u016bsu n\u0101kotni<\/p>\n<p>T\u012bmek\u013ca izst\u0101d\u0113 CES 2026 jaunuz\u0146\u0113mums NuraLogix prezent\u0113jis revolucion\u0101ru viedier\u012bci \u2013 Longevity Mirror. \u0160is pilna auguma spogulis, izmantojot ieb\u016bv\u0113tu kameru un m\u0101ksl\u012bg\u0101 intelekta algoritmus, sp\u0113j 30 sekun\u017eu laik\u0101 nov\u0113rt\u0113t cilv\u0113ka vesel\u012bbas r\u0101d\u012bt\u0101jus un nekav\u0113joties att\u0113lot rezult\u0101tus. K\u0101 inform\u0113 port\u0101ls NRA, \u0161\u012b tehnolo\u0123ija sola sniegt ieskatu par cilv\u0113ka ilgtermi\u0146a vesel\u012bbas prognoz\u0113m, balstoties uz anal\u012bz\u0113m, kas sp\u0113j prognoz\u0113t vesel\u012bbas riskus l\u012bdz pat 20 gadiem uz priek\u0161u. Longevity Mirror ir paredz\u0113ts individu\u0101lai lieto\u0161anai, lai pal\u012bdz\u0113tu cilv\u0113kiem lab\u0101k izprast savu pa\u0161reiz\u0113jo vesel\u012bbas st\u0101vokli un vesel\u012bbas trajektoriju. P\u0113rn CES izst\u0101d\u0113 NuraLogix iepaz\u012bstin\u0101ja ar Anura Magic Mirror, kas pied\u0101v\u0101ja l\u012bdz\u012bgas vesel\u012bbas anal\u012bzes, ta\u010du nebija pieejams pla\u0161ai publikai. Jaunais Longevity Mirror b\u016bs pieejams ieg\u0101dei jau 2026. gada s\u0101kum\u0101.<\/p>\n<p>K\u0101 darbojas Longevity Mirror?<\/p>\n<p>Longevity Mirror pamat\u0101 izmanto NuraLogix patent\u0113to Transdermal Optical Imaging (TOI) tehnolo\u0123iju. T\u0101s darb\u012bbas princips balst\u0101s uz sejas asins pl\u016bsmas mode\u013cu anal\u012bzi, izmantojot standarta video pa\u0161bildi. \u0160ie neredzamie asins pl\u016bsmas sign\u0101li tiek apstr\u0101d\u0101ti ar datorredzes un m\u0101ksl\u012bg\u0101 intelekta algoritmiem, kas apm\u0101c\u012bti uz simtiem t\u016bksto\u0161u pacientu datu. Ier\u012bce sp\u0113j nov\u0113rt\u0113t vair\u0101kus vesel\u012bbas r\u0101d\u012bt\u0101jus, tostarp kardiovaskul\u0101ro un vielmai\u0146as slim\u012bbu risku, fiziolo\u0123isko jeb biolo\u0123isko vecumu, ment\u0101l\u0101 stresa l\u012bmeni un sirds vesel\u012bbu. Rezult\u0101ti tiek summ\u0113ti \u201cLongevity Index\u201d punktu sist\u0113m\u0101, kas sv\u0101rst\u0101s no nulles l\u012bdz 100, sniedzot kop\u0113jo vesel\u012bbas nov\u0113rt\u0113jumu un prognozi par ilgtermi\u0146a vesel\u012bbu. \u0160\u012b metode ir unik\u0101la ar savu nekontakt\u0113jo\u0161o pieeju, jo nav nepiecie\u0161ama asins, ur\u012bna vai siekalu anal\u012bze. Lai gan spogulis sniedz t\u016bl\u012bt\u0113ju atgriezenisko saiti, da\u017ei m\u0113r\u012bjumi, piem\u0113ram, asinsspiediens, joproj\u0101m ir FDA izskat\u012b\u0161anas proces\u0101.<\/p>\n<p>Viedier\u012bces pied\u0101v\u0101t\u0101s iesp\u0113jas un cenas<\/p>\n<p>Longevity Mirror pied\u0101v\u0101 ne tikai vesel\u012bbas r\u0101d\u012bt\u0101ju anal\u012bzi, bet ar\u012b integr\u0113tu m\u0101ksl\u012bg\u0101 intelekta vesel\u012bbas asistentu, kas sp\u0113j izskaidrot ieg\u016btos datus un sniegt personaliz\u0113tus ieteikumus miega, fizisko aktivit\u0101\u0161u, uztura un stresa p\u0101rvald\u012bbas jom\u0101. Ier\u012bce atbalsta l\u012bdz pat se\u0161iem lietot\u0101ju profiliem, padarot to piem\u0113rotu lieto\u0161anai \u0123imen\u0113. Lietot\u0101jiem b\u016bs pieejama ar\u012b papildu \u201cOne-Touch Health Concierge\u201d pakalpojums, kas nodro\u0161ina savienojumu ar vesel\u012bbas un labsaj\u016btas speci\u0101listiem, piem\u0113ram, uztura speci\u0101listiem un vesel\u012bbas kou\u010diem. Longevity Mirror pl\u0101nots laist klaj\u0101 2026. gada s\u0101kum\u0101, un t\u0101 mazumtirdzniec\u012bbas cena b\u016bs 899 ASV dol\u0101ri, kas ietver viena gada abonementu. Turpm\u0101k gad\u0101 abonements maks\u0101s 99 ASV dol\u0101rus. Papildu \u201cOne-Touch Health Concierge\u201d pakalpojums maks\u0101s s\u0101kot no 399 ASV dol\u0101riem gad\u0101, atkar\u012bb\u0101 no pieejam\u012bbas un vesel\u012bbas partneru t\u012bkla.<\/p>\n<p>Inov\u0101cijas un ekspertu viedok\u013ci<\/p>\n<p>Longevity Mirror ir da\u013ca no pla\u0161\u0101k\u0101s \u201clongevity tech\u201d jeb dz\u012bves ilguma tehnolo\u0123iju tendences, kas arvien vair\u0101k izpau\u017eas tehnolo\u0123iju izst\u0101d\u0113s, piem\u0113ram, CES. \u0160\u012bs tehnolo\u0123ijas bie\u017ei vien tiek izmantotas, lai pal\u012bdz\u0113tu cilv\u0113kiem uzlabot savu dz\u012bves kvalit\u0101ti un paildzin\u0101t vesel\u012bgu dz\u012bves ilgumu, balstoties uz ikdienas l\u0113mumiem. Tom\u0113r tehnolo\u0123iju un vesel\u012bbas eksperti br\u012bdina par iesp\u0113jamo m\u0113r\u012bjumu precizit\u0101ti un datu priv\u0101tuma jaut\u0101jumiem, \u012bpa\u0161i laik\u0101, kad tiek mazin\u0101ts regul\u0113jums saist\u012bb\u0101 ar visp\u0101r\u0113j\u0101s labkl\u0101j\u012bbas produktiem. Lai gan AI tehnolo\u0123ij\u0101m ir potenci\u0101ls medic\u012bnas nozar\u0113, t\u0101s var veicin\u0101t aizspriedumus un sniegt neprec\u012bzu inform\u0101ciju. T\u0101p\u0113c ir svar\u012bgi atcer\u0113ties, ka \u0161\u0101das tehnolo\u0123ijas nevar piln\u012bb\u0101 aizst\u0101t kvalific\u0113tu medic\u012bnas speci\u0101listu.<\/p>\n","protected":false},"excerpt":{"rendered":"Jaun\u0101k\u0101s tehnolo\u0123ijas CES 2026: Spogulis, kas var nolas\u012bt j\u016bsu n\u0101kotni T\u012bmek\u013ca izst\u0101d\u0113 CES 2026 jaunuz\u0146\u0113mums NuraLogix prezent\u0113jis revolucion\u0101ru&hellip;\n","protected":false},"author":2,"featured_media":98740,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[77,76,17962,35,39,38,36,37,34,24213,40,87,24214,3995],"class_list":{"0":"post-98739","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-bizness","8":"tag-bizness","9":"tag-business","10":"tag-ces-2026","11":"tag-latvia","12":"tag-latvian","13":"tag-latviesu","14":"tag-latviesu-valoda","15":"tag-latviesuvaloda","16":"tag-latvija","17":"tag-longevity-mirror","18":"tag-lv","19":"tag-maksligais-intelekts","20":"tag-nuralogix","21":"tag-veselibas-tehnologijas"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@lv\/115861979311977436","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/98739","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/comments?post=98739"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/98739\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media\/98740"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media?parent=98739"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/categories?post=98739"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/tags?post=98739"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}